AKT1 and cancer: The role of native ghrelin in cancer is not fully understood, but studies suggest that effects are dependent on cell type and levels of this hormone; native ghrelin likely has proliferative effects at low doses through the activation of the PI3K/Akt pathway (Figure 2 and Figure 3).